Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Rodrigues

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2025
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of RegistriesRomain Aymon, Denis Mongin, Romain Guemara, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)Romain Aymon, Denis Mongin, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registryPedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.
Acta Reumatologica Portuguesa|November 15, 2012
[Portuguese recommendations for pain management by pharmocotherapy in inflammatory arthritis]Inês Silva, Ana F Mourão, Sofia Ramiro, et al.
Research Square|September 2, 2025
Sensitive dLight for imaging broad-spectrum dopamine events across brain regionsLin Tian, Jacob Roshgadol, Julie Chouinard, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Immunity|June 12, 2026
Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionBarnabas G Williams, Jordan R Barrett, Josefin Bartholdson Scott, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 updateAna Catarina Duarte, Daniela Santos-Faria, Maria João Gonçalves, et al.
Cell Reports. Medicine|July 17, 2024
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodiesLloyd D W King, David Pulido, Jordan R Barrett, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 updateCatia Duarte, Joana Sousa-Neves, Ana Águeda, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2025
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of RegistriesRomain Aymon, Denis Mongin, Romain Guemara, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)Romain Aymon, Denis Mongin, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registryPedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.
Acta Reumatologica Portuguesa|November 15, 2012
[Portuguese recommendations for pain management by pharmocotherapy in inflammatory arthritis]Inês Silva, Ana F Mourão, Sofia Ramiro, et al.
Research Square|September 2, 2025
Sensitive dLight for imaging broad-spectrum dopamine events across brain regionsLin Tian, Jacob Roshgadol, Julie Chouinard, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Immunity|June 12, 2026
Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionBarnabas G Williams, Jordan R Barrett, Josefin Bartholdson Scott, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 updateAna Catarina Duarte, Daniela Santos-Faria, Maria João Gonçalves, et al.
Cell Reports. Medicine|July 17, 2024
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodiesLloyd D W King, David Pulido, Jordan R Barrett, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 updateCatia Duarte, Joana Sousa-Neves, Ana Águeda, et al.
Pageof 20